Search alternatives:
mean decrease » a decrease (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), gy decreased (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), teer decrease (Expand Search)
c decrease » c decreased (Expand Search), _ decrease (Expand Search), a decrease (Expand Search)
Showing 121 - 140 results of 65,179 for search '(( 2 c decrease ) OR ( 5 ((((nn decrease) OR (mean decrease))) OR (we decrease)) ))', query time: 1.11s Refine Results
  1. 121
    m<sup>5</sup>C modified sites C131 and C2017 positively regulate HBV replication.

    m<sup>5</sup>C modified sites C131 and C2017 positively regulate HBV replication. by Jiangpeng Feng (9287738)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  2. 122
    Shoot-to-root translocation of GmNN1/FT2a regulates soybean nodulation.

    Shoot-to-root translocation of GmNN1/FT2a regulates soybean nodulation. by Xinxin Li (281237)

    Published 2022
    Save to List
    Saved in:
  3. 123
    Table5_Effects of exercise modalities on decreased blood pressure in patients with hypertension.docx

    Table5_Effects of exercise modalities on decreased blood pressure in patients with hypertension.docx by Thiago Rozales Ramis (5311217)

    Published 2022
    Save to List
    Saved in:
  4. 124
    GSK343 decreased viability and proliferation in human neuroblastoma PDX cells.

    GSK343 decreased viability and proliferation in human neuroblastoma PDX cells. by Laura V. Bownes (10276762)

    Published 2021
    “…GSK343 treatment resulted in significantly decreased viability. (B) COA3 and COA6 (1.5 × 10<sup>3</sup>) cells were treated with increasing concentrations of GSK343 (0, 5, 15, 25 μM) for 24 hours and proliferation was measured using CellTiter<sup>®</sup> assay. …”
    Save to List
    Saved in:
  5. 125
    NSC population and proliferation decrease drastically during the second postnatal week of DG development.

    NSC population and proliferation decrease drastically during the second postnatal week of DG development. by Cristina Medina-Menéndez (21800157)

    Published 2025
    Save to List
    Saved in:
  6. 126
    The decrease or inhibition of Hsp90 induced REST degradation.

    The decrease or inhibition of Hsp90 induced REST degradation. by Raúl Orozco-Díaz (7067624)

    Published 2019
    “…<p>(A) Effect of Hsp90α ASO on cell viability. Differentiated SH-SY5Y cells were transfected with different concentrations of Hsp90α ASO. …”
    Save to List
    Saved in:
  7. 127
    SARS-CoV-2 decreases excitatory synapses, while influenza A does not induce cell death in BCO.

    SARS-CoV-2 decreases excitatory synapses, while influenza A does not induce cell death in BCO. by Pinar Mesci (14053895)

    Published 2022
    Save to List
    Saved in:
  8. 128
    Positional cloning of <i>qNN1</i> on chromosome 16.

    Positional cloning of <i>qNN1</i> on chromosome 16. by Xinxin Li (281237)

    Published 2022
    Save to List
    Saved in:
  9. 129
    Osr1 heterozygous mice experienced decreased bile acid synthesis in the liver.

    Osr1 heterozygous mice experienced decreased bile acid synthesis in the liver. by Ernest C. Lynch (12769954)

    Published 2022
    “…Osr1 female mice had significantly increased gene expression of <i>Plin4</i> and <i>Plin5</i>. Data is presented as Mean±SD, N = 5; *p<0.05.…”
    Save to List
    Saved in:
  10. 130
    Significantly decreased adhesion to host cells by the Δ<i>tad123</i> mutant (A) and time-dependent recovery (B).

    Significantly decreased adhesion to host cells by the Δ<i>tad123</i> mutant (A) and time-dependent recovery (B). by Tra-My Duong-Nu (7300970)

    Published 2019
    Save to List
    Saved in:
  11. 131
    Data_Sheet_1_TMPRSS2 gene polymorphism common in East Asians confers decreased COVID-19 susceptibility.docx

    Data_Sheet_1_TMPRSS2 gene polymorphism common in East Asians confers decreased COVID-19 susceptibility.docx by Takeshi Sekiya (14194334)

    Published 2022
    Save to List
    Saved in:
  12. 132
    Antibody and antigen responses after treatment with nMAb vs placebo, day 1-90 (pooled nMAb treatments).

    Antibody and antigen responses after treatment with nMAb vs placebo, day 1-90 (pooled nMAb treatments). by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 133
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 134
    Antibody and antigen responses to Ensovibep vs placebo day 1–90.

    Antibody and antigen responses to Ensovibep vs placebo day 1–90. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 135
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 136
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 137
    Baseline patient characteristics across neutralizing monoclonal antibody trials.

    Baseline patient characteristics across neutralizing monoclonal antibody trials. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 138
    Antibody and antigen responses to Lufotrelvir vs placebo day 1–90.

    Antibody and antigen responses to Lufotrelvir vs placebo day 1–90. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 139
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Sotrovimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Sotrovimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 140
    Antibody and antigen responses by baseline anti-spike neutralizing response assay positivity.

    Antibody and antigen responses by baseline anti-spike neutralizing response assay positivity. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: